Acerus 
Welcome,         Profile    Billing    Logout  
 4 Products   1 Disease  4 Products   2 Trials   438 News 
6 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Natesto (testosterone) / Acerus, Medac, Aytu BioPharma
NCT04976595: A Study to Monitor Ambulatory Blood Pressure Monitoring in Hypogonadal Men Treated With Nasal Testosterone Gel

Recruiting
4
218
US
Natesto, Testosterone Nasal Gel
Acerus Pharmaceuticals Corporation
Hypogonadism
12/22
12/22
NCT05381831: Natesto Spermatogenesis Reboot

Completed
4
13
US
NatestoTM
University of Florida, Acerus Pharmaceutical
Hypogonadism, Male
04/25
04/25
NCT04439799: A Comparison of Side Effects in Hypogonadal Men Treated With Natesto Versus Testosterone Injections

Completed
4
81
US
Testosterone Cypionate 200 Mg/ML, Intranasal Testosterone, Natesto
University of Miami, Acerus Pharmaceuticals Corporation
Hypogonadism, Male
02/23
02/23
2017-001012-11: A multicenter, open label, variable dose, two arm pilot paediatric phase 1 PK study to evaluate testosterone nasal gel (4.5% w/w) in hypogonadal boys

Not yet recruiting
1
20
Europe
Natesto™/TBS-1, Natesto™, Nasal gel, Natesto®
Acerus Biopharma Inc., Acerus Biopharma Inc.
Primary and secondary hypogonadism, Primary and secondary hypogonadism, Body processes [G] - Biological Phenomena [G16]
 
 
NCT06130449: Testosterone and Neural Function

Recruiting
1
15
US
Natesto testosterone intranasal gel, testosterone intranasal gel, Ayr Saline Nasal Gel, Saline Nasal Gel
VA Office of Research and Development
Spinal Cord Injury
12/25
03/26
NCT04717362: The Effects of Natesto For Treatment Of Hypogonadism

Withdrawn
1
40
NA
Natesto Nasal Product
Baylor College of Medicine
Hypogonadism, Male, Infertility, Male, Testosterone Deficiency
12/24
12/24
TBS-5 / Acerus
No trials found
TBS-3 / Acerus
No trials found
Lidbree (lidocaine topical gel) / Palette Life Sci, Acerus
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Natesto (testosterone) / Acerus, Medac, Aytu BioPharma
NCT04976595: A Study to Monitor Ambulatory Blood Pressure Monitoring in Hypogonadal Men Treated With Nasal Testosterone Gel

Recruiting
4
218
US
Natesto, Testosterone Nasal Gel
Acerus Pharmaceuticals Corporation
Hypogonadism
12/22
12/22
NCT05381831: Natesto Spermatogenesis Reboot

Completed
4
13
US
NatestoTM
University of Florida, Acerus Pharmaceutical
Hypogonadism, Male
04/25
04/25
NCT04439799: A Comparison of Side Effects in Hypogonadal Men Treated With Natesto Versus Testosterone Injections

Completed
4
81
US
Testosterone Cypionate 200 Mg/ML, Intranasal Testosterone, Natesto
University of Miami, Acerus Pharmaceuticals Corporation
Hypogonadism, Male
02/23
02/23
2017-001012-11: A multicenter, open label, variable dose, two arm pilot paediatric phase 1 PK study to evaluate testosterone nasal gel (4.5% w/w) in hypogonadal boys

Not yet recruiting
1
20
Europe
Natesto™/TBS-1, Natesto™, Nasal gel, Natesto®
Acerus Biopharma Inc., Acerus Biopharma Inc.
Primary and secondary hypogonadism, Primary and secondary hypogonadism, Body processes [G] - Biological Phenomena [G16]
 
 
NCT06130449: Testosterone and Neural Function

Recruiting
1
15
US
Natesto testosterone intranasal gel, testosterone intranasal gel, Ayr Saline Nasal Gel, Saline Nasal Gel
VA Office of Research and Development
Spinal Cord Injury
12/25
03/26
NCT04717362: The Effects of Natesto For Treatment Of Hypogonadism

Withdrawn
1
40
NA
Natesto Nasal Product
Baylor College of Medicine
Hypogonadism, Male, Infertility, Male, Testosterone Deficiency
12/24
12/24
TBS-5 / Acerus
No trials found
TBS-3 / Acerus
No trials found
Lidbree (lidocaine topical gel) / Palette Life Sci, Acerus
No trials found

Download Options